درباره ما
NATO STANAG 2242
POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS - ED 1
Organization:
NATO - North Atlantic Treaty Organization
Year: 2005
Abstract: The aim of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that cause infectious disease.
Collections
:
-
Statistics
NATO STANAG 2242
Show full item record
| contributor author | NATO - North Atlantic Treaty Organization | |
| date accessioned | 2017-09-04T17:35:36Z | |
| date available | 2017-09-04T17:35:36Z | |
| date copyright | 05/10/2005 | |
| date issued | 2005 | |
| identifier other | DILXHBAAAAAAAAAA.pdf | |
| identifier uri | http://yse.yabesh.ir/std;jsery=autho162sear79D40AC42/handle/yse/158527 | |
| description abstract | The aim of this agreement is to develop a unified approach in NATO doctrine and policy in the use of chemoprophylaxis and immunotherapy by NATO personnel against Biological Warfare (BW) agents that cause infectious disease. | |
| language | English | |
| title | NATO STANAG 2242 | num |
| title | POLICY FOR THE CHEMOPROPHYLAXIS AND IMMUNOTHERAPY OF NATO PERSONNEL AGAINST BIOLOGICAL WARFARE AGENTS - ED 1 | en |
| type | standard | |
| page | 10 | |
| status | Active | |
| tree | NATO - North Atlantic Treaty Organization:;2005 | |
| contenttype | fulltext |